VX-993
VX23-993-002
Phase 1 small_molecule completed
Quick answer
VX-993 for Pain is a Phase 1 program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 6 ClinicalTrials.gov record(s).
Program details
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Indication
- Pain
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed